These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16225502)

  • 1. Proton-pump inhibitor for peptic ulcer bleeding.
    Zullo A; Hassan C; Morini S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):891-2; author reply 892. PubMed ID: 16225502
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
    Triadafilopoulos G
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.
    Bardou M; Toubouti Y; Benhaberou-Brun D; Rahme E; Barkun AN
    Aliment Pharmacol Ther; 2005 Mar; 21(6):677-86. PubMed ID: 15771753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
    Tsai JJ; Lin HJ
    Gastrointest Endosc; 2010 Jul; 72(1):223-4; author reply 224-5. PubMed ID: 20620284
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding peptic ulcers: what's new?
    Mönkemüller KE; Eloubeidi MA
    Gastrointest Endosc; 2002 Jul; 56(1):153-7; discussion 157-9. PubMed ID: 12108425
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Jul; 20(2):195-202. PubMed ID: 15233700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors in acute peptic ulcer bleeding.
    Rockey DC
    Gastroenterology; 2005 Aug; 129(2):756-7. PubMed ID: 16083731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 11. Explaining divergent results of meta-analyses on proton pump inhibitor treatment for ulcer bleeding.
    Leontiadis GI; Sharma VK; Howden CW
    Gastroenterology; 2005 Nov; 129(5):1804-5. PubMed ID: 16285985
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of gastroduodenal hemorrhages in pediatric cardiac surgery].
    Khar'kin AV; Lobacheva GV; Manerova AF; Abramian MA; Savchenko MV
    Anesteziol Reanimatol; 2005; (1):38-41. PubMed ID: 15839223
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic management of peptic ulcer bleeding].
    Wasielica-Berger J; Baniukiewicz A; Laszewicz W
    Wiad Lek; 2004; 57(9-10):499-504. PubMed ID: 15765769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors.
    Barry A
    Ir Med J; 1994; 87(5):134. PubMed ID: 7960649
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative dosing for PPI therapy: rationale and options.
    Johnson DA
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S10-5. PubMed ID: 14671509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Savides TJ; Pratha V
    Gastrointest Endosc; 2001 Jul; 54(1):130-2. PubMed ID: 11447983
    [No Abstract]   [Full Text] [Related]  

  • 19. It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
    Barkun AN; Kuipers EJ; Sung JJ
    Am J Gastroenterol; 2009 Aug; 104(8):2120-1. PubMed ID: 19661947
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proton pump inhibitors in bleeding stomach ulcer?].
    Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2006 Mar; 168(10):1024-6. PubMed ID: 16522294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.